Skip to main content
. 2023 May 31;14:1151502. doi: 10.3389/fimmu.2023.1151502

Table 3.

HLA haplotype analysis of HLA-A, -C, -B, -DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 in Japanese PBC patients and Japanese healthy controls.

A~B Control % PBC % OR (95%CI) P-value Pc-value
33:03:01~44:03:01 375 8.1 93 2.8 0.33 (0.26–0.42) 2.22E-16 4.88E-15
24:02:01~07:02:01 270 5.8 134 4.1 0.69 (0.55–0.85) 4.70E-04 1.03E-02
11:01:01~15:01:01 130 2.8 55 1.7 0.59 (0.42–0.82) 9.89E-04 2.18E-02
24:02:01~40:02:01 82 1.8 93 2.8 1.61 (1.18–2.21) 1.61E-03 3.54E-02
C~B Control % PBC % OR (95%CI) P-value Pc-value
14:03:01~44:03:01 418 9.0 106 3.2 0.34 (0.27–0.42) 2.22E-16 3.77E-15
04:01:01~15:01:01 158 3.4 62 1.9 0.54 (0.40–0.74) 4.66E-05 7.92E-04
07:02:01~07:02:01 324 7.0 165 5.0 0.70 (0.58–0.85) 3.14E-04 5.33E-03
01:02:01~46:01:01 254 5.5 246 7.4 1.39 (1.16–1.68) 3.20E-04 5.43E-03
03:04:01~40:02:01 260 5.6 248 7.5 1.37 (1.14–1.65) 5.62E-04 9.55E-03
08:01:01~40:06:01 171 3.7 171 5.2 1.43 (1.14–1.79) 1.14E-03 1.95E-02
A~C~B Control % PBC % OR (95%CI) P-value Pc-value
33:03:01~14:03:01~44:03:01 375 9.3 93 3.2 0.33 (0.26–0.42) 2.22E-16 4.44E-15
11:01:01~04:01:01~15:01:01 120 3.0 37 1.3 0.43 (0.29–0.63) 4.00E-06 8.00E-05
24:02:01~07:02:01~07:02:01 270 6.7 135 4.7 0.69 (0.56–0.86) 5.97E-04 1.19E-02
DRB1~DQB1 Control % PBC % OR (95%CI) P-value Pc-value
13:02:01~06:04:01 388 8.3 75 2.3 0.26 (0.20–0.33) 2.22E-16 3.55E-15
08:03:02~06:01:01 385 8.3 456 13.8 1.77 (1.53–2.05) 2.73E-15 4.37E-14
04:05:01~04:01:01 617 13.3 596 18.0 1.44 (1.27–1.63) 5.10E-09 8.17E-08
15:01:01~06:02:01 342 7.3 142 4.3 0.57 (0.46–0.69) 1.99E-08 3.19E-07
08:02:01~04:02:01 85 1.8 108 3.3 1.82 (1.35–2.45) 3.78E-05 6.05E-04
04:06:01~03:02:01 170 3.7 68 2.1 0.55 (0.41–0.74) 3.84E-05 6.15E-04
12:01:01~03:01:01 151 3.2 62 1.9 0.57 (0.42–0.77) 1.94E-04 3.10E-03
01:01:01~05:01:01 336 7.2 176 5.3 0.72 (0.60–0.88) 6.92E-04 1.11E-02
DRB1~DQB1~DPB1 Control % PBC % OR (95%CI) P-value Pc-value
13:02:01~06:04:01~04:01:01 268 6.1 40 1.3 0.20 (0.14–0.28) 2.22E-16 4.44E-15
04:05:01~04:01:01~05:01:01 345 7.9 389 12.4 1.67 (1.43–1.95) 3.55E-11 7.10E-10
08:03:02~06:01:01~05:01:01 197 4.5 254 8.1 1.88 (1.55–2.29) 5.17E-11 1.03E-09
15:01:01~06:02:01~02:01:02 144 3.3 40 1.3 0.38 (0.26–0.55) 3.59E-08 7.18E-07
04:06:01~03:02:01~02:01:02 121 2.8 44 1.4 0.51 (0.35–0.72) 9.10E-05 1.82E-03
01:01:01~05:01:01~04:02:01 242 5.5 115 3.7 0.66 (0.52–0.83) 2.60E-04 5.20E-03
08:03:02~06:01:01~02:02:01 79 1.8 95 3.0 1.71 (1.25–2.35) 4.01E-04 8.03E-03
DRB1~DQA1~DQB1 Control % PBC % OR (95%CI) P-value Pc-value
13:02:01~01:02:01~06:04:01 388 8.3 75 2.3 0.26 (0.20–0.33) 2.22E-16 3.33E-15
08:03:02~01:03:01~06:01:01 385 8.3 456 13.8 1.77 (1.53–2.05) 2.73E-15 4.10E-14
04:05:01~03:03:01~04:01:01 617 13.3 595 18.0 1.44 (1.27–1.63) 6.30E-09 9.44E-08
15:01:01~01:02:01~06:02:01 342 7.3 142 4.3 0.57 (0.46–0.69) 1.99E-08 2.99E-07
04:06:01~03:01:01~03:02:01 170 3.7 68 2.1 0.55 (0.41–0.74) 3.84E-05 5.77E-04
08:02:01~04:01:01~04:02:01 85 1.8 107 3.2 1.80 (1.34–2.43) 5.25E-05 7.88E-04
01:01:01~01:01:01~05:01:01 336 7.2 176 5.3 0.72 (0.60–0.88) 6.92E-04 1.04E-02
A~C~B~DRB1~DQA1~DQB1~DPB1 Control % PBC % OR (95%CI) P-value Pc-value
33:03:01~14:03:01~44:03:01~13:02:01~01:02:01~06:04:01~04:01:01 223 4.8 31 0.9 0.19 (0.12–0.28) 2.22E-16 1.78E-15
24:02:01~07:02:01~07:02:01~01:01:01~01:01:01~05:01:01~04:02:01 187 4.0 86 2.6 0.64 (0.49–0.83) 6.28E-04 5.03E-03
24:02:01~12:02:02~52:01:01~15:02:01~01:03:01~06:01:01~09:01:01 382 8.2 341 10.3 1.29 (1.10–1.50) 1.24E-03 9.94E-03

OR, odds ratio; 95%CI, 95% confidence interval; Pc-value, multiple testing-corrected p-value; binned, rare HLA alleles with expected count < 5, combined into a common class.